ALS – When the body has given up, but the brain persists

The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and wit...

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...

Björn Arvidsson: ”We need to change perspective”

If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network ...

Upcoming event: New updates on drugs

At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...

Alligator tar in nästan 200 miljoner för utveckling av cancerkandidat

Styrelsen för Lundbaserade Alligator Bioscience har beslutat om en nyemission på upp till 199 miljoner kronor. Fokus ligger nu framförallt på den fortsatta utve...

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

"Imponerande kraftsamling gav vaccin"

Det rekordsnabba framtagandet av nya vaccin under pandemin visar vad läkemedelsindustrin – och mänskligheten – kan åstadkomma när pressen är tillräckligt stor.

Samuel Lagercrantz: Collaboration and joint efforts are the key to success

Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...

Microbionical

Microbiotech/se AB

Synergon AB - Göteborg

Mindre antibiotika till djur

Försäljningen i Europa har minskat med 32 procent sedan 2011, visar ny rapport.

Stor kartläggning av svensk läkemedelsutveckling - "Väldigt imponerande bidrag"

Trots tuffa tider planerar två av tre life science-bolag att nyrekrytera – och antalet läkemedelsprojekt fortsätter att öka. Det visar branschorganisationen Swe...

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Orexo AB

Moberg derma får 32 miljoner

Meda ska sälja Moberg dermas nagelsvampspreparat i Europa.

Medicover expanderar i Norge – köper fertilitetsklinker

Vård- och diagnostikföretaget Medicover, baserat i Stockholm, har köpt 70 procent av röstandelarna i den norska fertilitetsverksamheten Klinikk Hausken. Det är ...

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Swedish and Danish Life Science – are there still untapped synergies?

With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish ...

Moberg Derma AB

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Bra start på donationsåret i Skåne

Den medicinska forskningen vid Skånes universitetssjukhus har redan dragit in 32 miljoner kronor på donationer.